News - China to Test Bird Flu Vaccine in Humans

China is readying a trial of bird flu vaccine to be tested on adults over the next year, according to a report published Thursday in the official China Daily newspaper.


As reported by the Associated Press, Lu Zhenyou, a spokesman for vaccine developer Sinovac Biotech, told the paper that 100 people aged 18 to 60 will be tested with the vaccine in the two-phase trial.


Should it prove successful in protecting against the H5N1 strain, the vaccine would first be given to high-risk groups, such as poultry farmers and veterinary and lab workers.

ABC News: Health�Highlights: Nov.�24,�2005